- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interferon gamma
Total 2454 results
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University HospitalTerminatedChronic Myeloid LeukemiaNetherlands, Denmark, Sweden, Finland, Norway
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
King Abdulaziz Medical CityCompleted
-
EMD SeronoPfizerCompletedMultiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Pregnancy | Prenatal Exposure Delayed EffectsUnited States
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
French National Agency for Research on AIDS and...Hoffmann-La RocheCompleted
-
Vir Biotechnology, Inc.Alnylam PharmaceuticalsActive, not recruitingChronic Hepatitis BAustralia, Hong Kong, Korea, Republic of, Malaysia, New Zealand, Thailand
-
Kexing Biopharm Co., Ltd.The Third Hospital of Changsha; Guoxin Pharmaceutical Technology (Beijing)... and other collaboratorsCompleted
-
Seoul National University HospitalRoche Pharma AG; SciClone PharmaceuticalsCompletedChronic Hepatitis BKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
University of ArizonaCompleted
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Switzerland, Netherlands, Poland, Finland, Belgium, United Kingdom, Austria, Germany, Italy, Israel, Slovakia, Spain, Serbia, Portugal, Russian Federation, Bulgaria, Croatia, Turkey, Estonia, Sweden
-
Intarcia TherapeuticsCompletedHepatitis CRussian Federation
-
PD Dr. Marcus MüllerBfARM, Bonn; DZNE, BonnUnknownRelapsing-remitting Multiple SclerosisGermany
-
BiogenCompletedActive Ulcerative ColitisUnited States, Canada, Czech Republic, Hungary, Poland, Russian Federation, Slovakia
-
Beijing Ditan HospitalUnknown
-
Tongji HospitalUnknownCOVID-19 | Recombinant Human Interferon α1β
-
Merck Sharp & Dohme LLCCompletedChronic Hepatitis CUnited States, Puerto Rico
-
José Antonio CarrionInstituto de Salud Carlos IIICompletedChronic Hepatitis B (HBeAg-negative)
-
Merck Sharp & Dohme LLCCompleted
-
Beijing Bio-Fortune Ltd.Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | LeukemiaPuerto Rico, United States, Switzerland, Canada
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Synairgen Research Ltd.Completed
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BayerCompleted
-
Merck Sharp & Dohme LLCCompleted
-
BayerCompleted
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
PV-NordCompleted
-
BayerCompletedMultiple Sclerosis | Clinically Isolated SystemKorea, Republic of
-
BiogenTerminatedMultiple SclerosisUnited States
-
Trio Medicines Ltd.BiogenCompleted
-
Chinese University of Hong KongHoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
EMD SeronoTerminatedCrohn's DiseaseGermany, Italy, Sweden, Switzerland, United Kingdom
-
UPECLIN HC FM Botucatu UnespCompletedHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedBrazil
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
BiogenAMS Advanced Medical Services GmbHCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Enyo PharmaCompletedHepatitis B, ChronicHong Kong, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)National Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV InfectionUnited States
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey